Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells

Research output: Contribution to journalReview article

105 Scopus citations

Fingerprint Dive into the research topics of 'Update on clinical experience with AMD3100, an SDF-1/CXCL12-CXCR4 inhibitor, in mobilization of hematopoietic stem and progenitor cells'. Together they form a unique fingerprint.

Medicine & Life Sciences